Complementarily, X-linked FAAH2 hemizygous loss-of-function variants have been described in humans presenting neurological features and metabolic disturbances, including obesity and hepatic steatosis [42]. Here, FAAH2 is linked to obesity due to melanocortin 4 receptor deficiency.